Related Experiment Video
Updated: Jul 10, 2026

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
Sensorimotor integration is abnormal in asymptomatic Parkin mutation carriers: a TMS study
T Bäumer1, P P Pramstaller, H R Siebner
1Department of Neurology, University of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany. baeumer@uke.de
Parkin gene mutation carriers show reduced sensorimotor inhibition, even before motor symptoms appear. This suggests early cortical changes in Parkinson disease (PD) related to dopaminergic dysfunction.
Area of Science:
- Neuroscience
- Genetics
- Neurology
Background:
- Parkinson disease (PD) is linked to reduced sensorimotor cortex inhibition.
- It's unclear if this inhibition deficit is due to motor symptoms or compensatory changes from dopaminergic neuron degeneration.
- This study investigates subclinical changes in asymptomatic Parkin mutation carriers.
Purpose of the Study:
- To probe intracortical sensorimotor excitability in asymptomatic carriers of a single mutant Parkin allele.
- To determine if reduced sensorimotor inhibition is present before the onset of motor symptoms in PD.
- To differentiate between adaptive changes and direct effects of the Parkin mutation on cortical excitability.
Main Methods:
- Used short-interval afferent inhibition (dSAI) and paired-pulse transcranial magnetic stimulation (TMS).
- Investigated nine heterozygous Parkin mutation carriers and nine healthy controls.
- Tested sensorimotor inhibition at specific interstimulus intervals (ISIs) for dSAI and paired-pulse TMS.
Main Results:
- Reduced dSAI was observed at a 25 msec ISI in Parkin mutation carriers.
- Intracortical paired-pulse TMS measures of inhibition and facilitation remained normal.
- These findings indicate a specific deficit in sensorimotor inhibition in preclinical PD.
Conclusions:
- The observed decrease in sensorimotor inhibition may stem directly from the Parkin mutation.
- Alternatively, it could represent adaptive cortical changes in response to subcortical dopaminergic dysfunction.
- This reduced inhibition is not attributable to motor symptoms, highlighting its preclinical nature.
More Related Videos
09:52Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation
Published on: February 23, 2020
14:47Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning
Published on: April 21, 2023
Related Concept Videos
Alterations in Muscle Tone lll
Neural Regulation
Parkinson Disease ll: Pathophysiology